These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 26121434

  • 1. SIGNIFICANT ELEVATION OF GROWTH HORMONE LEVEL IMPACTS SURGICAL OUTCOMES IN ACROMEGALY.
    Anthony JR, Alwahab UA, Kanakiya NK, Pontell DM, Veledar E, Oyesiku NM, Ioachimescu AG.
    Endocr Pract; 2015 Sep; 21(9):1001-9. PubMed ID: 26121434
    [Abstract] [Full Text] [Related]

  • 2. Impact of tumor characteristics and pre- and postoperative hormone levels on hormonal remission following endoscopic transsphenoidal surgery in patients with acromegaly.
    Cardinal T, Rutkowski MJ, Micko A, Shiroishi M, Jason Liu CS, Wrobel B, Carmichael J, Zada G.
    Neurosurg Focus; 2020 Jun; 48(6):E10. PubMed ID: 32480366
    [Abstract] [Full Text] [Related]

  • 3. [Outcome of surgical treatment for acromegaly performed by a single neurosurgeon and cumulative meta-analysis].
    Boeving A, Borba LA, Rodrigues AM, Orichowski EB, Paz Filho GJ, Santos CM, Boguszewski CL.
    Arq Bras Endocrinol Metabol; 2006 Oct; 50(5):884-92. PubMed ID: 17160212
    [Abstract] [Full Text] [Related]

  • 4. Postoperative GH and Degree of Reduction in IGF-1 Predicts Postoperative Hormonal Remission in Acromegaly.
    Cardinal T, Collet C, Wedemeyer M, Singer PA, Weiss M, Zada G, Carmichael JD.
    Front Endocrinol (Lausanne); 2021 Oct; 12():743052. PubMed ID: 34867787
    [Abstract] [Full Text] [Related]

  • 5. Age- and Sex-Specific Differences as Predictors of Surgical Remission Among Patients With Acromegaly.
    Park SH, Ku CR, Moon JH, Kim EH, Kim SH, Lee EJ.
    J Clin Endocrinol Metab; 2018 Mar 01; 103(3):909-916. PubMed ID: 29272449
    [Abstract] [Full Text] [Related]

  • 6. Long-term endocrinological follow-up evaluation in 115 patients who underwent transsphenoidal surgery for acromegaly.
    Freda PU, Wardlaw SL, Post KD.
    J Neurosurg; 1998 Sep 01; 89(3):353-8. PubMed ID: 9724106
    [Abstract] [Full Text] [Related]

  • 7. Transsphenoidal surgery for acromegaly: predicting remission with early postoperative growth hormone assays.
    Sarkar S, Jacob KS, Pratheesh R, Chacko AG.
    Acta Neurochir (Wien); 2014 Jul 01; 156(7):1379-87; discussion 1387. PubMed ID: 24781680
    [Abstract] [Full Text] [Related]

  • 8. Prognostic Factors of Acromegalic Patients with Growth Hormone-Secreting Pituitary Adenoma After Transsphenoidal Surgery.
    Taweesomboonyat C, Oearsakul T.
    World Neurosurg; 2021 Feb 01; 146():e1360-e1366. PubMed ID: 33309643
    [Abstract] [Full Text] [Related]

  • 9. Body mass index and insulin-like growth factor 1 as risk factors for discordant growth hormone and insulin-like growth factor 1 levels following pituitary surgery in acromegaly.
    Zhang S, Li Y, Guo X, Gao L, Lian W, Yao Y, Feng M, Bao X, Wang R, Xing B.
    J Formos Med Assoc; 2018 Jan 01; 117(1):34-41. PubMed ID: 28341329
    [Abstract] [Full Text] [Related]

  • 10. Low insulin resistance after surgery predicts poor GH suppression one year after complete resection for acromegaly: a retrospective study.
    Edo N, Morita K, Suzuki H, Takeshita A, Miyakawa M, Fukuhara N, Nishioka H, Yamada S, Takeuchi Y.
    Endocr J; 2016 May 31; 63(5):469-77. PubMed ID: 26949262
    [Abstract] [Full Text] [Related]

  • 11. Endoscopic endonasal transsphenoidal surgery for growth hormone-secreting pituitary adenomas.
    Hofstetter CP, Mannaa RH, Mubita L, Anand VK, Kennedy JW, Dehdashti AR, Schwartz TH.
    Neurosurg Focus; 2010 Oct 31; 29(4):E6. PubMed ID: 20887131
    [Abstract] [Full Text] [Related]

  • 12. Endoscopic vs microsurgical transsphenoidal surgery for acromegaly: outcomes in a concurrent series of patients using modern criteria for remission.
    Starke RM, Raper DM, Payne SC, Vance ML, Oldfield EH, Jane JA.
    J Clin Endocrinol Metab; 2013 Aug 31; 98(8):3190-8. PubMed ID: 23737543
    [Abstract] [Full Text] [Related]

  • 13. Predictors of surgical outcome and early criteria of remission in acromegaly.
    Antunes X, Ventura N, Camilo GB, Wildemberg LE, Guasti A, Pereira PJM, Camacho AHS, Chimelli L, Niemeyer P, Gadelha MR, Kasuki L.
    Endocrine; 2018 Jun 31; 60(3):415-422. PubMed ID: 29626274
    [Abstract] [Full Text] [Related]

  • 14. Pure endoscopic transsphenoidal surgery for treatment of acromegaly: results of 67 cases treated in a pituitary center.
    Gondim JA, Almeida JP, de Albuquerque LA, Gomes E, Schops M, Ferraz T.
    Neurosurg Focus; 2010 Oct 31; 29(4):E7. PubMed ID: 20887132
    [Abstract] [Full Text] [Related]

  • 15. Long-Term Effects of Intracapsular Debulking and Adjuvant Somatostatin Analogs for Growth Hormone-Secreting Pituitary Macroadenoma: 10 Years of Experience in a Single Institute.
    Shen SC, Shen CC, Pu TW, Cheng WY.
    World Neurosurg; 2019 Jun 31; 126():e41-e47. PubMed ID: 30716503
    [Abstract] [Full Text] [Related]

  • 16. Long-term follow-up of patients with surgical intractable acromegaly after linear accelerator radiosurgery.
    Yan JL, Chang CN, Chuang CC, Hsu PW, Lin JD, Wei KC, Lee ST, Tseng JK, Pai PC, Chen YL.
    J Formos Med Assoc; 2013 Jul 31; 112(7):416-20. PubMed ID: 23927981
    [Abstract] [Full Text] [Related]

  • 17. 2010 versus the 2000 consensus criteria in patients with normalised insulin-like growth factor 1 after transsphenoidal surgery has high predictive values for long-term recurrence-free survival in acromegaly.
    Shen M, Chen Z, Shou X, He W, Qiao N, Ma Z, Ye Z, Zhang Y, Zhang Q, Zhou X, Cao X, Zhang Z, Ye H, Li Y, Zhao Y, Li S, He M, Wang Y.
    J Neuroendocrinol; 2021 May 31; 33(5):e12958. PubMed ID: 33998086
    [Abstract] [Full Text] [Related]

  • 18. Revisiting the Role of Insulin-like Growth Factor-1 Measurement After Surgical Treatment of Acromegaly.
    Jung IH, Choi S, Ku CR, Lee SG, Lee EJ, Kim SH, Kim EH.
    J Clin Endocrinol Metab; 2021 Jun 16; 106(7):e2589-e2599. PubMed ID: 33738470
    [Abstract] [Full Text] [Related]

  • 19. Outcomes after a purely endoscopic transsphenoidal resection of growth hormone-secreting pituitary adenomas.
    Campbell PG, Kenning E, Andrews DW, Yadla S, Rosen M, Evans JJ.
    Neurosurg Focus; 2010 Oct 16; 29(4):E5. PubMed ID: 20887130
    [Abstract] [Full Text] [Related]

  • 20. Endoscopic Transsphenoidal Approach for Acromegaly with Remission Rates in 401 Patients: 2010 Consensus Criteria.
    Anik I, Cabuk B, Gokbel A, Selek A, Cetinarslan B, Anik Y, Ceylan S.
    World Neurosurg; 2017 Dec 16; 108():278-290. PubMed ID: 28887283
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.